Clinical Trial to Evaluate the Efficacy of Neuromuscular Electrical Stimulation Therapy in Patients With Sarcopenia

ConditionSarcopenia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-85
SponsorExosystems

About this trial

The goal of this clinical trial is to exploratorily evaluate the safety and efficacy of a home-based lower extremity muscle strengthening and physical performance enhancement program using Neuromuscular Electrical Stimulation (NMES) devices.

Participants will apply NMES stimulation to both thighs for 8 weeks, at a frequency of at least 4 times per week.

Eligibility criteria

Qualifiers

Diagnosed with sarcopenia according to the Asian Working Group for Sarcopenia (2019) criteria

Able to perform the exercise program provided by the investigators, with sufficient physical and cognitive function

Able to understand the study explanation and provide voluntary informed consent

Able to operate a mobile phone independently or with assistance from a caregiver

Disqualifiers

Any prior surgical procedure on either knee (right or left) 2) Recent Knee Injection or Procedure

Receipt of any injection or interventional procedure in either knee within the past 3 months 3) Ongoing Treatment for Knee Pain

Currently receiving medication or physical therapy for knee pain 4) Implanted Electrical Devices

Presence of an implanted electrical device (e.g., pacemaker, electrical stimulator) 5) Seizure Disorder

Trial design

Treatments tested in this trial

  • neuromuscular electrical stimulation

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Exosystems

Lead sponsor

The Catholic University of Korea

Collaborator